Prat A, Solovieff N, Andre F, O'Shaughnessy J, et al. Intrinsic subtype and overall survival of patients with advanced HR+/HER2- breast cancer treated with ribociclib and ET: correlative analysis of MONALEESA-2, -3, -7. Clin Cancer Res 2023 Nov 8. doi: 10.1158/1078-0432.CCR-23-0561.
PMID: 37939142